Delivery Order SPE2DB22D1106-SPE2DB25FEJM1

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.20 fixed-price delivery order is for AZSTARYS CAPS 26.1MG/5.2MG, a pharmaceutical product, with a performance period ending on May 19, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,893.00, is a Firm Fixed Price Delivery Order contract for the pharmaceutical product AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,096.07, is a firm fixed-price delivery order for AZSTARYS CAPS 52.3MG/10.4MG. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,531.52 and an ultimate completion date of March 17, 2025. It is a delivery order contract for the supply of pharmaceutical products, including AZSTARYS capsules, with a firm fixed price pricing type. The contract is not designated as a set-aside....
This federal contract award, valued at $2,685.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX22D0010|SPE2D825FFM60) for the pharmaceutical product AZSTARYS CAPS 52.3MG/10.4MG, with a performance period ending on May 8, 2025. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,983.06, is for the supply of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,017.85 and covers the delivery of the medication AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract is not set aside and has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical and medical products, including medications such as Azstarys capsules. The contract has a ceiling value of $4,769.82 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The total ceiling value of the contract is $1,630.88, with a period of performance through June 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...
This is a $5,408.10 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for AZSTARYS CAPS 39.2MG/7.8MG medical supplies. The contract is not set-aside and has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a global pharmaceutical support vehicle through...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEJM1
    Delivery Order

This federal contract award, valued at $1,259.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication AZSTARYS 39.2 MG-7.8 MG CAP 100S, with a completion date of April 21, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 7/18/25, 9:53 AM